About Rockwell Medical
Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Major
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Symbol: RMTI
- CUSIP: 77437410
- Previous Close: $5.83
- 50 Day Moving Average: $5.99
- 200 Day Moving Average: $6.46
- 52-Week Range: $3.55 - $10.58
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 194.33
- P/E Growth: -0.79
- Market Cap: $300.40M
- Outstanding Shares: 51,527,000
- Beta: 1.92
- Net Margins: -37.98%
- Return on Equity: -33.60%
- Return on Assets: -22.85%
Companies Related to Rockwell Medical:
- Current Ratio: 10.91%
- Quick Ratio: 9.31%
What is Rockwell Medical's stock symbol?
Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
Where is Rockwell Medical's stock going? Where will Rockwell Medical's stock price be in 2017?
5 brokers have issued 1 year target prices for Rockwell Medical's stock. Their predictions range from $5.00 to $12.00. On average, they expect Rockwell Medical's stock price to reach $8.00 in the next twelve months.
When will Rockwell Medical announce their earnings?
Rockwell Medical is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
What are analysts saying about Rockwell Medical stock?
Here are some recent quotes from research analysts about Rockwell Medical stock:
According to Zacks Investment Research, "Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly. " (1/20/2017)
BTIG Research analysts commented, "We see RMTI shares as significantly undervalued at the current level with Triferic (projected peak sales of $180+ million), Calcitriol (peak sales of $48+ million) and a base business with a revenue run rate of ~$50 million," analyst Ling Wang wrote in a note.Related Link: Portolas AndexXa Still Approvable, But It Will Take TimeAlthough there is a near-term delay in Triferic ramp-up due to pursuing transitional add-on reimbursement, the analyst views the effort as worthwhile, given the added incentive for dialysis providers."Our Buy recommendation is not based on securing transitional add-on reimbursement. Rather, we believe Triferic's value proposition remains intact even without it," (8/19/2016)
Who owns Rockwell Medical stock?
Rockwell Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Robert L Chioini (9.20%), State Street Corp (1.71%), Perritt Capital Management Inc. (0.09%), Metropolitan Life Insurance Co. NY (0.07%), State Board of Administration of Florida Retirement System (0.05%) and Cutter & CO Brokerage Inc. (0.05%). Company insiders that own Rockwell Medical stock include Kenneth L Holt, Raymond Dennis Pratt, Robert L Chioini and Ronald D Boyd.
Who sold Rockwell Medical stock? Who is selling Rockwell Medical stock?
Rockwell Medical's stock was sold by a variety of institutional investors in the last quarter, including Metropolitan Life Insurance Co. NY.
Who bought Rockwell Medical stock? Who is buying Rockwell Medical stock?
Rockwell Medical's stock was purchased by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc., Cutter & CO Brokerage Inc., State Street Corp and Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Rockwell Medical stock in the last two years include Raymond Dennis Pratt and Robert L Chioini.
How do I buy Rockwell Medical stock?
Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Rockwell Medical stock cost?
One share of Rockwell Medical stock can currently be purchased for approximately $5.83.